Science Explorer Back to mapMap
Discussion
Company · Rozzano · Italy

Lusofarmaco (Italy)

Research works
53
fractional, all time
Citations
509
9.6 per fractional work
Top-10% rate
9.0%
all institutions 10.0%
Open access
17%
world 40%
International
8%
world 18%

Not ranked overall: Lusofarmaco (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Lusofarmaco (Italy) work in?

In all years, 35% of research at Lusofarmaco (Italy) is in Health Sciences, 35% in Physical Sciences. Its largest fields are Medicine (33%), Chemistry (29%), Biochemistry, Genetics and Molecular Biology (13%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 19 fractional works · 35.2% of its workMedicine: 18 fractional works · 33.2% of its workCardiology and Cardiovascular Medicine: 3 fractional works · 4.7% of its workPsychiatry and Mental health: 2 fractional works · 4.3% of its workImmunology and Allergy: 1 fractional works · 2.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.5% of its workPhysiology: 1 fractional works · 2.3% of its workPathology and Forensic Medicine: 1 fractional works · 2.2% of its workPharmacology: 1 fractional works · 2.1% of its workComplementary and alternative medicine: 1 fractional works · 1.6% of its workOncology: 1 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.4% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.4% of its workInfectious Diseases: 1 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.9% of its workEpidemiology: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.6% of its workObstetrics and Gynecology: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 1.9% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workSpeech and Hearing: 0 fractional works · 0.6% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workPhysical Sciences: 19 fractional works · 35.1% of its workChemistry: 16 fractional works · 29.2% of its workOrganic Chemistry: 14 fractional works · 26.3% of its workAnalytical Chemistry: 1 fractional works · 1.3% of its workSpectroscopy: 1 fractional works · 1.1% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.6% of its workComputer Science: 2 fractional works · 2.9% of its workComputational Theory and Mathematics: 1 fractional works · 1.7% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.6% of its workHuman-Computer Interaction: 0 fractional works · 0.6% of its workMaterials Science: 1 fractional works · 1.3% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.6% of its workEarth and Planetary Sciences: 0 fractional works · 0.6% of its workGeology: 0 fractional works · 0.6% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workCondensed Matter Physics: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workLife Sciences: 12 fractional works · 22.3% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 13.3% of its workMolecular Biology: 5 fractional works · 9.5% of its workGenetics: 1 fractional works · 1.9% of its workBiochemistry: 0 fractional works · 0.9% of its workCancer Research: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workNeuroscience: 2 fractional works · 4.0% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.0% of its workCognitive Neuroscience: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.2% of its workPharmacology: 1 fractional works · 1.3% of its workPharmaceutical Science: 0 fractional works · 0.9% of its workAgricultural and Biological Sciences: 1 fractional works · 2.0% of its workFood Science: 0 fractional works · 0.6% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.5% of its workInsect Science: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 0.8% of its workImmunology: 0 fractional works · 0.5% of its workParasitology: 0 fractional works · 0.3% of its workSocial Sciences: 4 fractional works · 7.4% of its workArts and Humanities: 2 fractional works · 4.7% of its workReligious studies: 1 fractional works · 2.5% of its workPhilosophy: 1 fractional works · 1.3% of its workHistory: 0 fractional works · 0.9% of its workSocial Sciences: 1 fractional works · 1.9% of its workCommunication: 0 fractional works · 0.6% of its workPolitical Science and International Relations: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 0.5% of its workSocial Psychology: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKLusofarmaco(Italy)53fractional works, all years
Life Sciences22%Physical Sciences35%Health Sciences35%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine1833.2%
    2. Health Professions11.9%
    3. Nursing00.1%
    1. Chemistry1629.2%
    2. Computer Science22.9%
    3. Materials Science11.3%
    4. Earth and Planetary Sciences00.6%
    5. Physics and Astronomy00.6%
    6. Environmental Science00.4%
    1. Biochemistry, Genetics and Molecular Biology713.3%
    2. Neuroscience24.0%
    3. Pharmacology, Toxicology and Pharmaceutics12.2%
    4. Agricultural and Biological Sciences12.0%
    5. Immunology and Microbiology00.8%
    1. Arts and Humanities24.7%
    2. Social Sciences11.9%
    3. Psychology00.5%
    4. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Lusofarmaco (Italy)?

Ranked on the quality score, Giuseppe Cascio, D Pezzola and Aldo Salimbeni lead among researchers whose main affiliation is Lusofarmaco (Italy).

  1. 1 Giuseppe Cascio Italy · #3,411,829 worldwide 237 citations · 18 works
  2. 2 D Pezzola Italy · #3,580,506 worldwide 139 citations · 23 works
  3. 3 Aldo Salimbeni Italy · #4,182,232 worldwide 206 citations · 20 works
  4. 4 Tea Chieli Italy · #4,638,686 worldwide 194 citations · 25 works
  5. 5 Elso Manghisi Italy · #5,206,519 worldwide 171 citations · 31 works
  6. 6 Dario Zava Italy · #5,327,338 worldwide 395 citations · 37 works
  7. 7 Alvise Fattorello Salimbeni Italy · #5,678,160 worldwide 96 citations · 42 works
  8. 8 Giancarlo B. Fregnan Italy · #6,192,185 worldwide 543 citations · 63 works
All ranked researchers at Lusofarmaco (Italy)

What are the most cited papers from Lusofarmaco (Italy)?

The most cited paper from Lusofarmaco (Italy) is "PHARMACOLOGY OF NEBIVOLOL" (Mario Mangrella, Francesca Rossi, Francesco Fıcı et al., 1998), with 100 citations. Next come "Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice" (61) and "N-3-Substituted Pyrimidinones as Potent, Orally Active, AT1 Selective Angiotensin II Receptor Antagonists" (60).

Most cited papers
#PaperReleasedCitations
1 PHARMACOLOGY OF NEBIVOLOL Mario Mangrella, Francesca Rossi, Francesco Fıcı et al. · Pharmacological Research Dec 1998 100
2 Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice Filomena de Nigris, Francesco Paolo D’Armiento, Pasquale Somma et al. · International Journal of Cardiology Dec 2001 61
3 N-3-Substituted Pyrimidinones as Potent, Orally Active, AT1 Selective Angiotensin II Receptor Antagonists Aldo Salimbeni, Renato Canevotti, Fabio Paleari et al. · Journal of Medicinal Chemistry Open access Nov 1995 60
4 Comparison Between Outdoor and Indoor Airborne Allergenic Activity Gennaro D’Amato, María Julieta Russo, Gennaro Liccardi et al. · Annals of Allergy Asthma & Immunology Aug 1996 57
5 A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine Lidia Savi, Stefano Omboni, Carlo Lisotto et al. · The Journal of Headache and Pain Open access 4 Aug 2010 46
All 87 most cited papers, with filters and sorting

Which keywords describe research at Lusofarmaco (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Synthesis, Medicinal Chemistry, Heterocycles, Catalyst, Drug Discovery, Anticancer Agents, Biological Evaluation and Chemoselective.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Synthesis11▲ 35×10 topics
  2. Medicinal Chemistry6▲ 30×5 topics
  3. Heterocycles6▲ 59×5 topics
  4. Catalyst4▲ 79×2 topics
  5. Drug Discovery4▲ 19×4 topics
  6. Inflammation4▲ 3.1×11 topics
  7. Anticancer Agents4▲ 26×4 topics
  8. Biological Evaluation4▲ 53×4 topics
  9. Epidemiology3▲ 1.52×8 topics
  10. Chemoselective3▲ 42×2 topics
  11. Hypertension3▲ 14×7 topics
  12. Imidazoles3▲ 183×1 topic
  13. Oxazolones3▲ 183×1 topic
  14. Heterocyclic Compounds2▲ 30×2 topics
  15. Treatment2▲ 3.4×5 topics
  16. Antimicrobial2▲ 16×4 topics
  17. Antimicrobial Activity2▲ 21×2 topics
  18. Cardiovascular Disease2▲ 3.8×6 topics
  19. Amination2▲ 138×1 topic
  20. Anticancer2▲ 20×4 topics
  21. Catalytic2▲ 26×1 topic
  22. Clinical Trials2▲ 5.8×4 topics
  23. Molecular Docking2▲ 25×2 topics
  24. Derivatives2▲ 57×1 topic
  25. Metabolism2▲ 5.3×7 topics
  26. Neurological Disorders2▲ 4.9×3 topics
  27. Quinoxaline2▲ 76×1 topic
  28. Organic Synthesis2▲ 15×2 topics
  29. Pharmacokinetics2▲ 11×3 topics
  30. Calcitonin Gene-Related Peptide2▲ 33×2 topics
  31. Nuclear Receptors2▲ 15×3 topics
  32. Pharmacology2▲ 8.7×2 topics
  33. Acidity Scales1▲ 102×1 topic
  34. Annulation1▲ 142×1 topic
  35. Breast Cancer1▲ 8.9×2 topics
  36. Ketene Dithioacetal1▲ 142×1 topic
  37. Microwave-Assisted Synthesis1▲ 31×2 topics
  38. Nucleophilicity1▲ 53×1 topic
  39. Surgery1▲ 7.7×2 topics
  40. Transcriptional Regulation1▲ 10.0×2 topics

Which research topics does Lusofarmaco (Italy) publish most on?

By volume in 2022-now: Virtual Reality Applications and Impacts, 3D Surveying and Cultural Heritage, Augmented Reality Applications and Enzyme Catalysis and Immobilization.

  1. 1 Virtual Reality Applications and Impacts Human-Computer Interaction 0 works
  2. 2 3D Surveying and Cultural Heritage Geology 0 works
  3. 3 Augmented Reality Applications Computer Vision and Pattern Recognition 0 works
  4. 4 Enzyme Catalysis and Immobilization Molecular Biology 0 works
  5. 5 Analytical Chemistry and Chromatography Spectroscopy 0 works
  6. 6 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.2%not open82.8%

World: 40% of research is openly available.

with international co-authors8.2%domestic only91.8%

World: 18% is written across borders.

How has Lusofarmaco (Italy)'s research output changed?

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Lusofarmaco (Italy) as a percentage of every work published that year, 0.000025% in 2014.

0.00025%0.00050%0.00075%Lusofarmaco (Italy)0.000018% in 202419801990200020102020

Fractional works of Lusofarmaco (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rozzano

All research institutions in Rozzano

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Lusofarmaco (Italy). Posts are plain text and can be reported.